Biomarin Pharmaceutical reported $11.67M in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.71M 23.06M
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Acorda Therapeutics ACOR:US $ -15.69M 13.09M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Amgen AMGN:US $ 828M 1301M
Arena Pharmaceuticals ARNA:US $ -144.39M 12.4M
Bayer BAYN:GR -2281000000 5.36B
Biogen BIIB:US $ 485.7M 488.2M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Gilead Sciences GILD:US $ 2246M 644M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Insmed INSM:US $ -106255000 22.42M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Ptc Therapeutics PTCT:US $ -98.49M 0.34M
Puma Biotechnology PBYI:US $ -1.73M 21.69M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Seattle Genetics SGEN:US $ -89.6M 32.82M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
United Therapeutics UTHR:US $ 219.9M 284.7M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
YTE INCY:US $ 140.84M 42.04M